Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-335 and Rosuvastatin Combination in Dyslipidemia
NCT00463606Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibric acid in dyslipidemia, hypercholesterolemia, sponsored by AstraZeneca. Started Apr 2007; status: completed.
02
Drugs
fenofibric acid
03
Conditions
dyslipidemiahypercholesterolemia
Beyond the preview
Go deeper on NCT00463606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463606.